+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

From
GLP-1 Analogues - Global Strategic Business Report - Product Thumbnail Image

GLP-1 Analogues - Global Strategic Business Report

  • Report
  • November 2025
  • 474 Pages
  • Global
From
Vaccines Market Overview, 2023-28 - Product Thumbnail Image

Vaccines Market Overview, 2023-28

  • Report
  • September 2023
  • 114 Pages
  • Global
From
Middle East & Africa Vaccines Market Outlook, 2028 - Product Thumbnail Image

Middle East & Africa Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 87 Pages
  • Middle East, Africa
From
South America Vaccines Market Outlook, 2028 - Product Thumbnail Image

South America Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 89 Pages
From
Asia-Pacific Vaccines Market Outlook, 2028 - Product Thumbnail Image

Asia-Pacific Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 107 Pages
  • Asia Pacific
From
Europe Vaccines Market Outlook, 2028 - Product Thumbnail Image

Europe Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 112 Pages
  • Europe
From
North America Vaccines Market Outlook, 2028 - Product Thumbnail Image

North America Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 101 Pages
  • North America
From
Vaccines Market Outlook, 2028 - Product Thumbnail Image

Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 194 Pages
  • Global
From
From
Transarterial Chemoembolization - Global Strategic Business Report - Product Thumbnail Image

Transarterial Chemoembolization - Global Strategic Business Report

  • Report
  • November 2025
  • 375 Pages
  • Global
From
Integrase Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Integrase Inhibitors - Global Strategic Business Report

  • Report
  • November 2025
  • 371 Pages
  • Global
From
Anti-Retroviral Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Retroviral Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 280 Pages
  • Global
From
From
From
Pancreatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Pancreatic Cancer Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 151 Pages
  • Global
From
Loading Indicator